XLVvsFHLCETF Comparison
VS
State Street Health Care Select Sector SPDR ETF (XLV) and Fidelity MSCI Health Care Index ETF (FHLC) belong to the same industry segment: US Health Care. XLV's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, FHLC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.084% for FHLC. XLV is up 18.57% year-to-date (YTD) with +$1.21B in YTD flows. FHLC performs worse with 18.15% YTD performance, and +$478M in YTD flows. Run a side-by-side ETF comparison of XLV and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV vs FHLC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/22/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV FHLC | +6.72%+5.36% | +14.19%+12.47% | +18.57%+18.15% | +26.26%+25.71% | +49.70%+52.61% | +49.31%+42.00% |
| Flows | XLV FHLC | +$1.66B+$73M | +$454M+$233M | +$1.21B+$478M | +$2.09B+$542M | -$3.45B-$187M | +$4.70B+$31M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV FHLC | +17.55%+16.88% | +16.30%+15.83% | +14.96%+14.92% | +15.25%+15.50% |
| Max drawdown | XLV FHLC | -5.81%-5.64% | -10.51%-10.35% | -17.05%-16.88% | -17.05%-17.78% |
| Max drawdown duration | XLV FHLC | 56d56d | 116d169d | 444d435d | 444d762d |
Trading data
XLV | FHLC | |
Last sale 10/22/2026 at 1:30 PM | $181.30 | $86.95 |
| Previous close 10/22/2026 | $178.94 | $85.91 |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLV | FHLC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/22/2026 at 1:30 PM
Live
Closed
XLV | FHLC | |
|---|---|---|
| Last price | $181.30 | $86.95 |
| 1D performance | +1.32% | +1.21% |
| AuM | $47.68 B | $3.86 B |
| E/R | 0.08% | 0.084% |
Characteristics
XLV | FHLC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | Fidelity |
| Benchmark | S&P Health Care Select Sector Index | MSCI USA IMI Health Care 25/50 Index |
| N° of holdings | 59 | 338 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | October 21, 2013 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLV
USA
97.52%
Other
2.48%
FHLC
USA
97.14%
Other
2.86%
Sectors
XLV
Healthcare
97.84%
Other
2.16%
FHLC
Healthcare
98.23%
Other
1.77%
Advertisement
Diversification
XLV
Total weight of top 15 holdings out of 15
71.32%
FHLC
Total weight of top 15 holdings out of 15
60.85%
Top 15 holdings
Data as of August 31, 2026
XLV
Eli Lilly & Co.
14.88%
Johnson & Johnson
10.41%
AbbVie, Inc.
7.37%
Merck & Co., Inc.
5.93%
UnitedHealth Group, Inc.
5.75%
Amgen, Inc.
3.77%
Thermo Fisher Scientific, Inc.
3.73%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.95%
Pfizer Inc.
2.64%
Vertex Pharmaceuticals, Inc.
2.25%
Bristol Myers Squibb Co.
2.22%
Danaher Corp.
2.19%
Intuitive Surgical, Inc.
2.17%
CVS Health Corp.
1.95%
FHLC
Eli Lilly & Co.
12.94%
Johnson & Johnson
8.88%
AbbVie, Inc.
6.21%
Merck & Co., Inc.
5.04%
UnitedHealth Group, Inc.
4.91%
Amgen, Inc.
3.21%
Thermo Fisher Scientific, Inc.
3.19%
Abbott Laboratories
2.69%
Gilead Sciences, Inc.
2.49%
Pfizer Inc.
2.19%
Vertex Pharmaceuticals, Inc.
1.90%
Danaher Corp.
1.89%
Bristol Myers Squibb Co.
1.87%
Intuitive Surgical, Inc.
1.82%
CVS Health Corp.
1.63%
Frequently asked questions about XLV and FHLC
How have the XLV and FHLC ETFs performed in 2026?
As of October 22, 2026, XLV is up 18.57% year-to-date (YTD), while FHLC has returned 18.15%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or FHLC?
Year-to-date, the XLV ETF saw +$1.21B in flows, compared to +$478M for FHLC.
Which ETF is more volatile: XLV or FHLC?
Over the past year, XLV had a volatility of 16.3%, while FHLC experienced 15.83%.
Which ETF is bigger: XLV or FHLC?
As of October 22, 2026, XLV holds $47.68 B in assets under management (AUM), while FHLC manages $3.86 B.
What sectors do the XLV and FHLC ETFs invest in?
XLV leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.
What are the top holdings of the XLV ETF and FHLC ETF?
XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: XLV or FHLC?
XLV holds 59 securities with 71.32% of its assets in the top 15. FHLC has 338 securities and a top 15 weight of 60.85%.
Advertisement
Latest news about XLV & FHLC
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
